Early Use of High-efficacy DMTs Favor Lesser Disability Over Time

Early Use of High-efficacy DMTs Favor Lesser Disability Over Time

297849

Early Use of High-efficacy DMTs Favor Lesser Disability Over Time

Long-term disability outcomes tend to be better in people with relapsing-remitting multiple sclerosis (RRMS) who are treated early on with highly effective therapies, a study based on patient registry data indicates. The study, “Long-term disability trajectories in relapsing multiple sclerosis patients treated with early intensive or escalation treatment strategies,” was published in Therapeutic Advances in Neurological Disorders. The MS treatment landscape has changed substantially in the past few decades, with many highly effective medicines being approved.…

You must be logged in to read/download the full post.